Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Farnesyl diphosphate synthase pseudogene 3 (FDPSP3) is a processed pseudogene that is similar in sequence to the functional gene encoding farnesyl diphosphate synthase (FDPS), but it does not produce a functional protein. As a pseudogene, FDPSP3 does not have known biological activity, disease associations, or roles as a drug target[1][2]. FDPSP3 should not be confused with the functional enzyme farnesyl diphosphate synthase (FDPS), which is an important enzyme target involved in isoprenoid biosynthesis and is therapeutically targeted by bisphosphonate drugs[3][5][7]. Pseudogenes like FDPSP3 are generally not considered therapeutic targets because they do not produce functional proteins[1][2]. There is no evidence for significant biological or therapeutic relevance of FDPSP3 itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Farnesyl diphosphate synthase pseudogene 3 (FDPSP3).